Strategy

Ex-Aetna Chief Bertolini Says CVS Bought His Company to Hide Problems

Mark Bertolini says CVS bought Aetna for nearly $70 billion to hide problems it "never really fixed," two weeks after CVS announced its split into two companies.

By Daniel Okafor

5 min read

The man who sold Aetna to CVS for almost $70 billion says the deal was cover for problems ‘they never really fixed’—just
The man who sold Aetna to CVS for almost $70 billion says the deal was cover for problems ‘they never really fixed’—just16081684 / pixabay

What's News

  • Bertolini sold Aetna to CVS for almost $70 billion in 2018; CVS shares fell 12.5%, losing about $15 billion, on the Nov. 4 split announcement.
  • CVS will spin off roughly 9,000 stores and MinuteClinic as CVS Pharmacy by the first half of 2028, keeping Aetna and Caremark.
  • Bertolini said 74% of large employers are considering defined contribution health funding.
  • Oscar Health posted Q3 net income of $167.3 million on revenue of $5.14 billion, up 72%.
  • Family employer premiums passed $28,000 in 2026, per KFF.

Mark Bertolini sold Aetna to CVS Health for almost $70 billion in 2018. On Monday, he told a room of Fortune 500 executives what he believes CVS was really buying.

"The real intention" of the purchase, Bertolini said at the Fortune 500 Innovation Forum in Detroit, "was just to take the earning stream and revenue stream from [Aetna] to hide a bunch of other things that they never really fixed." He tied the comment straight to the breakup CVS announced this month: "You'd never do that deal now."

The remarks land two weeks after CVS said it will split in two. CVS Health keeps Aetna and the Caremark pharmacy benefit manager. It spins off roughly 9,000 stores and MinuteClinic as a separate company, CVS Pharmacy, by the first half of 2028. CVS shares closed down 12.5% on Nov. 4, the day of the announcement, erasing nearly $15 billion in market value.

For employers, insurers, and anyone with a pharmacy benefit, the split partially unwinds the biggest bet on vertical integration in American health care.

CVS declined to comment on Bertolini's remarks. "This is the right decision, at the right time," CVS Health spokesperson David Whitrap said of the split in an email, adding that the company is "getting ahead of the external market dynamics from a position of strength. Each of our businesses are thriving." He confirmed Aetna and Caremark will stay together and that the separation should finish by mid-2028.

What happened to the 'front door' strategy?

Bertolini ran Aetna from 2011 through the sale and has led Oscar Health since April 2023. Asked by Fortune's Kristin Stroller whether he worried he had made the system worse, he started with what he called "an admission against self-interest": he was part of the team that took Express Scripts public, back when "we thought the PBM [pharmacy benefit manager] was a great idea."

"I thought it would never last, but it did," he said, comparing the PBM model to a card hustle on a New York street corner: "Where's the queen?"

The Aetna deal was pitched as something else. Bertolini called it "a new front door for health care," with customers shopping for care at the front of CVS stores. In 2017 he promoted it as "10,000 new front doors to the health care system." He said the vision "never got pulled through because it took a lot of intensity to do it," and he was moved to the board. On succession, he was blunt: "There can only be one CEO."

CVS cut him from its board in February 2020 as it shrank from 16 directors to 13. Bertolini told the Wall Street Journal he was being pushed out before the Aetna integration finished. A CVS spokesperson said then that "the board felt it was the right time for Mark to focus on his other endeavors."

The stores — the front door in his pitch — are now the piece CVS is cutting loose. Bertolini said the strategy stopped making sense after the pandemic and the shift to virtual care. CVS CEO David Joyner frames the split as a sign of health, not retreat.

"The businesses are running really well," he told Reuters. "We've been afforded the opportunity to make different decisions than we, than I could have two years ago."

Morningstar's Julie Utterback noted "CVS has the most exposure to vertical integration in the industry."

What would Bertolini remove from the system?

Asked what he would cut — even something his own company benefits from — Bertolini did not hesitate: "Eliminate employer-sponsored health insurance."

His argument is about bargaining power. Doctors, hospitals, and insurers consolidated to grab a bigger share, he said. An employer with 20,000 or 30,000 workers that could land a good network deal 15 years ago cannot anymore. Bertolini said 74% of large employers are now considering defined contribution, where the employer hands workers a set amount instead of a plan. He wants that money in portable accounts — HSAs or HRAs — that follow workers through job changes, gig work, and Medicaid or Medicare.

"Americans always pick the best solution last," he said.

Employers pay heavily for the current model. Family premiums for employer coverage passed $28,000 in 2026, with workers paying $7,471 of that, according to KFF's annual survey.

Zach Reitano, CEO of cash-pay telehealth company Ro, who shared the stage, gave the same answer. "Most frequently in the healthcare system, the patient is not the customer," he said, adding that this creates "suboptimal outcomes just based on incentives." He borrowed the old line about democracy: "In our mind, a patient is sort of the worst person to determine their healthcare except for everyone else."

How strong is Bertolini's own position?

Oscar, which sells plans mostly on the Affordable Care Act exchanges, reported third-quarter net income of $167.3 million, against a loss of $137.5 million a year earlier, on revenue of $5.14 billion, up 72%. Membership stood at about 2.69 million.

Onstage, Bertolini said 67% of Oscar's coding is now done by AI agents, that the company runs 40 large language models, and that it has taken $1.2 billion out of its operating costs over three years.

"We try everything else until we get the right one, which is the last one, and that's the consumer," he said.

CVS expects to complete the split in the first half of 2028. Aetna stays with Caremark, and the front door stands on its own — the clearest verdict yet on whether the $70 billion integration thesis ever worked.

Source: fortune.com

Share this article:

More from Daniel Okafor

Daniel Okafor

Show full bio

Correspondent covering money, funding and market shifts around entrepreneurship, startups and venture funding at Business Bearings.

2,282 articles

Related articles

« Previous articleNext article »